arrow
S

Suresh V. Ambudkar

national institutes of health
H指数:87
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tetrahydroquinoline/4,5-dihydroisoxazoline derivatives counteract multidrug resistance in cancer cells by inhibiting P-glycoprotein (ABCB1)-mediated transport

四氢喹啉/4,5-二氢异恶唑烷衍生物通过抑制P-糖蛋白(ABCB1)介导的转运来对抗癌细胞的耐药性

2025-12-040
PRE
Erratum to “The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs” [European Journal of Pharmaceutical Sciences (2025) 107337]

勘误:“第四代EGFR酪氨酸激酶抑制剂BLU-945使ABCG2过表达的耐多药非小细胞肺癌细胞对细胞毒性抗癌药物重新敏感”〔European Journal of Pharmaceutical Sciences (2025) 107337〕

2025-12-040
OAAI
Structure-activity relationship studies on 2-thienylidene substituted 3-oxo-2,3-dihydrobenzofuran-7-carboxamides as poly (ADP-ribose) polymerase inhibitors

2-噻吩基取代的3-氧代-2,3-二氢苯并呋喃-7-甲酰胺类化合物的构效关系研究,作为聚(ADP-核糖)聚合酶抑制剂

2025-09-050
PRE
Conversion of Human Multidrug Transporter P-glycoprotein (ABCB1) from Drug Efflux to Uptake Pump: Evidence for a Switch Region Modulating the Direction of Substrate Transport

人类多药转运蛋白P-糖蛋白(ABCB1)从药物外排泵到摄取泵的转换:支持存在调控底物转运方向的转换区域的证据

2025-04-011
PRE
Reserpine analog modulates transport function of ABCG2
2024-03-220
PRE